FDA
-
-
-
-
-
-
-
Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology Research
-
-
-
-
-
-
-
Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025
-
-
-
-
-
-
-
Lunit Awarded Major National Tender in France, Expanding Access to Breast AI in Public Hospitals
-
-
-
-
-
-
-
Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies
-
-
-
-
-
-
-
Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca
-
-
-
-
-
-
-
Lunit AI Enhances Precision in Predicting Outcomes for HER2-Targeted Therapy in Metastatic Colorectal Cancer - new study published in JCO Precision Oncology
-
-
-
-
-
-
-
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC
-
324,757 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

